Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus

Abstract

Diabetes mellitus (DM) is characterised by alterations in the intrarenal renin-angiotensin system (RAS). Insulin treatment may reverse these changes by an unknown mechanism. We aimed to verify the association between somatic ACE with 136 kDa (sACE) and N-domain ACE with 69 kDa (nACE) from Wistar (W) rat tissue with DM.Three groups were studied: control (CT), insulin treated diabetic (DT) and untreated (D). ACE activity was determined using Hippuryl-His-Leu and Z-Phe-His-Leu as substrates. In D group, urine ACE activity increased for both substrates when compared with CT and DT, despite the decreased activity of renal tissues. Immunostaining of renal tissue demonstrated that ACE is more strongly expressed in the proximaltubule of D than in the same nephron portion in the other groups. Angiotensin (Ang) 1-7 and Ang II are less expressed in DT group when compared with CT and D. Ang II levels decreased in the D and DT groups showed when compared to the control. Ang 1-7 was detected in all studied groups with low levels in DT.The modulation of angiotensin peptides suggests that sACE, nACE, ACE 2 and NEP could have important functions in renal RAS regulation through a counter-regulatory mechanism to protect the kidney in diabetes mellitus.

Keywords

angiotensin-converting enzyme diabetes mellitus angiotensins urine kidney

Get full access to this article

View all access options for this article.

References

Susman JL , Helseth LD Reducing the complications of type II diabetes: a patient-centered approach . Am Fam Physician 1997;56:471-80.

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the devlepomentr and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl L Med 1993;329: 977-36.

Traub O. , Van Bibber R. Role of nitric oxide in insulin-dependent diabetes mellitus related vascular complications. West J Med 1995;162:439-45.

Brands MW , Fitzgerald SM Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system. Am J Hypertens 2001;14:126S-131S.

Ustundag B. , Cay M. , Naziroglu M. , Dilsiz N. , Crabbe MJ , Ilhan N. The study of renin-angiotensin-aldosterone in experimental diabetes mellitus . Cell Biochem Funct 1999;17:193-8.

Wehbi GJ , Zimpelmann J. , Carey RM , Levine DZ , Burns KD Early streptozotocin-di Diabetes mellitus downregulates rat kidney AT2 receptors . Am J Physiol Renal Physiol 2001;280:F254-F265.

Zimpelmann J. , Kumar D. , Levine DZ , Wehbi G. et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int 2000;58:2320-30.mRNA ex essi n in the rat. Kidney Int 2000;58:2320-30.

Anderson S. , Jung FF , Ingelfinger JR Renal reninangiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993;265:F477-F486.

Zatz R. , Dunn BR , Meyer TW , Anderson S. , Rennke HG , Brenner BM Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986 ;77:1925-30.

10.

Gilbert RE , Cox A. , Wu LL et al. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition . Diabetes 1998;47:414-22.

11.

Erman A. , Chen-Gal B. , David I. , Giler S. , Boner G. , van Dijk DJ Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats. Scand J Clin Lab Invest 1998;58:81-7.

12.

Erman A. , van Dyk DJ , Chen-Gal B. , Giler ID , Rosenfeld JB , Boner G. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993;23:615-20.

13.

Given MB , Lowe RF , Gelvin CR , Sander GE , Giles TD Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic Dahl rat. Am J Hypertens 1994;7:919-25.

14.

Ottlecz A. , Bensaoula T. Captopril ameliorates the decreased Na+K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 1996;37:1633-41.

15.

Ottlecz A. , Bensaoula T. , Eichberg J. , Peterson RG Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity. Invest Ophthalmol Vis Sci 1996 ;37:2157-64.

16.

Goyal RK , Satia MC , Bangaru RA , Gandhi TP Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats. J Cardiovasc Pharmacol 1998;32:317-22.

17.

Vranes D. , Cooper ME , Dilley RJ Angiotensin-converting enzyme inhibition reduces diabetes-induced vascular hypertrophy: morphometric studies. J Vasc Res 1995;32:183-9.

18.

Sharifi AM , Mousavi SH , Larijani B. Study of interaction between nitric oxide and ACE activity in STZ-induced diabetic rats: role of insulin. Pharmacol Res 2004;50:261-6.

19.

Valentovic MA , Elliott CW , Ball JG The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res Commun Chem Pathol Pharmacol 1987;58:27-39.

20.

Burrell LM , Johnston CI , Tikellis C. , Cooper ME ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab 2004;15:166-9.

21.

Erdos EG Conversion of angiotensin I to angiotensin II. Am J Med 1976;60:749-59.

22.

Hall JE Historical perspective of the renin-angiotensin system. Mol Biotechnol 2003;24:27-39.

23.

Lattion AL , Soubrier F. , Allegrini J. , Hubert C. , Corvol P. , Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett 1989;252:99-104.

24.

Xiao HD , Fuchs S. , Frenzel K. , Teng L. , Bernstein KE Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE) . Crit Rev Eukaryot Gene Expr 2004;14:137-45.

25.

Casarini DE , Carmona AK , Plavnik FL , Zanella MT , Juliano L. , Ribeiro AB Calcium channel blockers as inhibitors of angiotensin I-converting enzyme. Hypertension 1995;26:1145-8.

26.

Casarini DE , Plavinik FL , Zanella MT et al. Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol 2001;33:75-85.

27.

Kokubu T. , Kato I. , Nishimura K. , Hiwada K. , Ueda E. Angiotensin I-converting enzyme in humanurine. Clin Chim Acta 1978;89:375-9.

28.

Tipnis SR , Hooper NM , Hyde R. , Karran E. , Christie G. , Turner AJ A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000;275:33238-43.

29.

Donoghue M. , Hsieh F. , Baronas E. etal. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-E9.

30.

Tikellis C. , Johnston CI , Forbes JM et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003;41:392-7.

31.

Riviere G. , Michaud A. , Breton C. et al. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutritionprogrammed hypertension in the adult rat. Hypertension 2005;46:1169-74.

32.

Ye M. , Wysocki J. , Naaz P. , Salabat MR , LaPointe MS , Batlle D.

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

Hypertension 2004;43:1120-5.

33.

Marques GD , Quinto BM , Plavinik FL , Krieger JE , Marson O. , Casarini DE N-domain angiotensin I-converting enzyme with 80 kDa as a possible genetic marker of hypertension. Hypertension 2003;42:693-701.

34.

Ronchi FA , Andrade MC , Carmona AK , Krieger JE , Casarini DE N-domain angiotensin-converting enzyme isoform expression in tissues of Wistar and spontaneously hypertensive rats. J Hypertens 2005;23: 1869-78.

35.

Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.

36.

Oliveira EM , Santos RA , Krieger JE Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats . Braz J Med Biol Res 2000;33:755-64.

37.

Friedland J. , Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976;66:416-24.

38.

Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.

39.

Wanless IR , Lentz JS Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10.

40.

Andersen S. , Tarnow L. , Rossing P. , Hansen BV , Parving HH Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000;57:601-06.

41.

Chan JC , Ko GT , Leung DH et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney Int 2000;57:590-600.

42.

Dzau VJ Circulating versus local renin-angiotensin system P in cardiovascular homeostasis . Circulation 1988;77:14-113.

43.

Sharifi AM , Li JS , Endemann D. , Schiffrin EL Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 1998;16:457-66.

44.

de Cavanagh EM , Inserra F. , Toblli J. , Stella I. , Fraga CG , Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 2001;38:1130-6.

45.

Remuzzi G. , Bertani T.

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

Kidney Int 1990;38:384-94.

46.

Siu B. , Saha J. , Smoyer WE , Sullivan KA , Brosius FC, 3rd. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 2006;7:6.

47.

Lieberman J. , Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 1980;93:825-6.

48.

Mezzano S. , Droguett A. , Burgos ME et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl 2003;86:S64-S70.

49.

Tschope C. , Reinecke A. , Seidl U. et al. Functional, biochemical, and molecular investigations of renal kallikreinkinin system in diabetic rats. Am J Physiol 1999;277:H2333-H2340.

50.

Casarini DE , Boim MA , Stella RC , Krieger-Azzolini MH , Krieger JE , Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 1997;272:F405-F409.

51.

Quinto BP , Casarini DE Identification of a new site of angiotensin I-converting enzyme (ACE) production in IMCD cells and study of interaction between the bradykinin receptor B2 and ACE using ACE inhibitor. J Hypertens 2002 ;20:S195.

52.

Santos RA , Campagnole-Santos MJ , Andrade SP Angiotensin-(1-7): an update. Regul Pept 2000 ;91:45-62.